Xencor, Inc.
Bispecific Antibodies That Bind to CD38 and CD3
Last updated:
Abstract:
The invention provides novel heterodimeric proteins including heterodimeric antibodies.
Status:
Application
Type:
Utility
Filling date:
30 Oct 2020
Issue date:
7 Oct 2021